Results 181 to 190 of about 756,649 (382)

Indolent cutaneous lymphoma with gamma/delta expression after COVID-19 vaccination. [PDF]

JAAD Case Rep, 2023
Hobayan CG, Chung CG.
europepmc   +1 more source

Cutaneous T-cell lymphomas: modern data of pathogenesis, clinics and therapy

, 2018
O.M. Demina, Oleg E. Akilov, A. G. Rumyantsev   +2 more
openalex   +2 more sources

Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group [PDF]

, 2017
Rutger C. Melchers, Rein Willemze, Laurien Daniëls, Karen J. Neelis, Marcel W. Bekkenk, E Haas, Barbara Horváth, Michelle M. van Rossum, Cornelus J. G. Sanders, Berit Velstra, JOEP C. J. M. VERAART, R.E.J. Roach, Maarten H. Vermeer, Koen D. Quint   +13 more
openalex   +1 more source

Cutaneous Hodgkin’s lymphoma

South Asian Journal of Cancer, 2017
Asawari Anant Ambekar, Chitralekha S Soman   +1 more
openaire   +3 more sources

The Role of SAMHD1 in Viral Resistance and Transduction Efficiency Challenges in Pediatric Hematological Malignancies: Mechanistic Insights and Clinical Perspectives

European Journal of Haematology, EarlyView.
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley   +1 more source

Epidemiology of cutaneous lymphoma. [PDF]

Br J Dermatol, 2021
Vermeer M.
europepmc   +1 more source

Dasatinib Produces Lengthy Remissions of Extramedullary Leukemia: A Retrospective Observational Study

European Journal of Haematology, EarlyView.
ABSTRACT Since 2004, patients receiving imatinib with relapse in non‐marrow sites were given dasatinib to preserve control of leukemic marrow. Remissions in CNS and other organs began to be reported and are continuously observed to present. With resistance to one BCR::ABL1 tyrosine kinase inhibitor and sensitivity to a dual BCR::ABL1/SRC inhibitor ...
I. Cunningham, R. A. Fisher, J. Yang, Y. Guo, U. Bommhardt   +4 more
wiley   +1 more source

Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry. [PDF]

J Eur Acad Dermatol Venereol, 2021
Sánchez-Velázquez A, Bauer-Alonso A, Estrach T, Vega-Díez D, Garcia-Muret P, Haya L, Peñate Y, Acebo E, Fernández de Misa R, Blanes M, Suh-Oh HJ, Izu R, Silva-Díaz E, Sarriugarte J, Román-Curto C, Botella-Estrada R, Mateu-Puchades A, Prieto-Torres L, Morillas V, Morillo M, Sánchez-Caminero P, Calzado L, Pérez-Ferriols A, Pérez A, Domínguez JD, Navedo M, Muniesa C, Combalia A, Arroyo-Andrés J, Descalzo MA, García-Doval I, Ortiz-Romero PL.   +31 more
europepmc   +1 more source

Restricted Expression of the Constant Region 1 of T‐Cell Receptor β by Flow Cytometry Facilitates Detection of T‐Cell Neoplasms With High Specificity but Moderate Predictive Value

European Journal of Haematology, EarlyView.
ABSTRACT Objectives To determine the diagnostic value of disclosing monotypic T‐cell populations by expression analysis of the constant region 1 of T‐cell receptor β (TRBC1) by flow cytometry, for the detection of T‐cell neoplasms, in a routine hematopathology practice setting.
Nilofar Rajabian, Olof Axler, Erik Wistén, Anna Porwit, Mats Ehinger   +4 more
wiley   +1 more source

A case of secondary syphilis masquerading as cutaneous lymphoma. [PDF]

JAAD Case Rep, 2021
Nethers K, Mojica RE, Marks E, Burger R, Saeed S, Steffes W.   +5 more
europepmc   +1 more source